Clinical Pipeline

Clinical Trials

To learn more about our ongoing clinical trials or to find out if a study is enrolling patients in your area, please visit www.clinicaltrials.gov or email clinical@kadmon.com.

CandidatePhaseStudy
Number
Indication
KD025PivotalKD025-213Chronic graft-versus-host disease (cGVHD) after at least 2 prior lines of systemic therapy
KD025Phase 2KD025-208Chronic graft-versus-host disease (cGVHD) after 1-3 prior lines of systemic therapy
KD025Phase 2KD025-209Diffuse Cutaneous Systemic Sclerosis (SSc)
KD025Phase 2KD025-207Idiopathic Pulmonary Fibrosis (IPF)
TesevatinibPhase 2KD019-211Autosomal Dominant Polycystic Kidney (ADPKD)